| Matthew Dehn Levac, MSOT OTR/L | |
|
16455 E Avenue Of The Fountains, Fountain Hills, AZ 85268-8307 | |
| (480) 836-5000 | |
| Not Available |
| Full Name | Matthew Dehn Levac |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 16455 E Avenue Of The Fountains, Fountain Hills, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902220122 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | Achievement Therapy Services |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265499701 PECOS PAC ID: 6800990953 Enrollment ID: O20181015001201 |
News Archive
Miss M. spends around 15 hours a week in hospital. Her renal functions are limited, and her kidneys are no longer able to filter toxins from her blood. She is a dialysis patient, forced to rely on this artificial blood purification treatment that, although essential, greatly impairs her quality of life. She has to make three trips a week to the dialysis clinic and going away for longer than a few days is almost out of the question. And Miss M. is no exception: In Germany alone, over six million people suffer from some form of chronic renal disease.
Increasing temperatures, water scarcity, availability of agricultural land, biodiversity loss and climate change threaten to reverse health gains seen over the last century.
Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 10:30 a.m. EDT at the Grand Hyatt New York Hotel in New York City.
Higher levels of a certain fat in the blood called ceramides may increase a person's risk of developing Alzheimer's disease, according to a study published in the July 18, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.
The American College of Physicians' Medical Laboratory Evaluation (MLE) program recently gained approval to offer certain analytes for use with the College of American Pathologists (CAP) Laboratory Accreditation Program (LAP). The CAP accreditation program is an internationally-recognized program that uses more rigorous standards than regulatory compliance to help labs achieve the highest standard of excellence. In order to qualify for accreditation, labs must perform proficiency testing on required analytes.
› Verified 2 days ago
| Provider Name | Theraplay4kidz, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750727798 PECOS PAC ID: 3476823972 Enrollment ID: O20190321000727 |
News Archive
Miss M. spends around 15 hours a week in hospital. Her renal functions are limited, and her kidneys are no longer able to filter toxins from her blood. She is a dialysis patient, forced to rely on this artificial blood purification treatment that, although essential, greatly impairs her quality of life. She has to make three trips a week to the dialysis clinic and going away for longer than a few days is almost out of the question. And Miss M. is no exception: In Germany alone, over six million people suffer from some form of chronic renal disease.
Increasing temperatures, water scarcity, availability of agricultural land, biodiversity loss and climate change threaten to reverse health gains seen over the last century.
Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 10:30 a.m. EDT at the Grand Hyatt New York Hotel in New York City.
Higher levels of a certain fat in the blood called ceramides may increase a person's risk of developing Alzheimer's disease, according to a study published in the July 18, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.
The American College of Physicians' Medical Laboratory Evaluation (MLE) program recently gained approval to offer certain analytes for use with the College of American Pathologists (CAP) Laboratory Accreditation Program (LAP). The CAP accreditation program is an internationally-recognized program that uses more rigorous standards than regulatory compliance to help labs achieve the highest standard of excellence. In order to qualify for accreditation, labs must perform proficiency testing on required analytes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Dehn Levac, MSOT OTR/L 8864 E Aster Dr, Scottsdale, AZ 85260-8430 Ph: (928) 978-2937 | Matthew Dehn Levac, MSOT OTR/L 16455 E Avenue Of The Fountains, Fountain Hills, AZ 85268-8307 Ph: (480) 836-5000 |
News Archive
Miss M. spends around 15 hours a week in hospital. Her renal functions are limited, and her kidneys are no longer able to filter toxins from her blood. She is a dialysis patient, forced to rely on this artificial blood purification treatment that, although essential, greatly impairs her quality of life. She has to make three trips a week to the dialysis clinic and going away for longer than a few days is almost out of the question. And Miss M. is no exception: In Germany alone, over six million people suffer from some form of chronic renal disease.
Increasing temperatures, water scarcity, availability of agricultural land, biodiversity loss and climate change threaten to reverse health gains seen over the last century.
Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 10:30 a.m. EDT at the Grand Hyatt New York Hotel in New York City.
Higher levels of a certain fat in the blood called ceramides may increase a person's risk of developing Alzheimer's disease, according to a study published in the July 18, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.
The American College of Physicians' Medical Laboratory Evaluation (MLE) program recently gained approval to offer certain analytes for use with the College of American Pathologists (CAP) Laboratory Accreditation Program (LAP). The CAP accreditation program is an internationally-recognized program that uses more rigorous standards than regulatory compliance to help labs achieve the highest standard of excellence. In order to qualify for accreditation, labs must perform proficiency testing on required analytes.
› Verified 2 days ago
Brian Paulsen, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15215 E Palisades Blvd, Fountain Hills, AZ 85268 Phone: 480-221-2573 | |
Mr. William Charles High, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16000 E Palisades Blvd, Fountain Hills, AZ 85268 Phone: 480-664-5018 | |
Lori Borowitz, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15410 E Acacia Way, Fountain Hills, AZ 85268 Phone: 513-260-5751 | |
Sarah Starkey, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17100 E Shea Blvd, 225, Fountain Hills, AZ 85268 Phone: 480-837-4565 | |
Katlyn Tavarres, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17100 E Shea Blvd Ste 600, Fountain Hills, AZ 85268 Phone: 480-837-4565 | |
Mrs. Allyson Zimmer, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17100 E Shea Blvd Ste 600, Fountain Hills, AZ 85268 Phone: 480-837-4565 | |
Dr. Rachael Magdalene Voysey, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17100 E Shea Blvd, Fountain Hills, AZ 85268 Phone: 732-272-4604 |